376 related articles for article (PubMed ID: 31086307)
21. Enzyme replacement therapy for infantile-onset Pompe disease.
Chen M; Zhang L; Quan S
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011539. PubMed ID: 29155436
[TBL] [Abstract][Full Text] [Related]
22. Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease.
Lin N; Huang J; Violante S; Orsini JJ; Caggana M; Hughes EE; Stevens C; DiAntonio L; Chieh Liao H; Hong X; Ghomashchi F; Babu Kumar A; Zhou H; Kornreich R; Wasserstein M; Gelb MH; Yu C
Clin Chem; 2017 Apr; 63(4):842-851. PubMed ID: 28196920
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.
Case LE; Bjartmar C; Morgan C; Casey R; Charrow J; Clancy JP; Dasouki M; DeArmey S; Nedd K; Nevins M; Peters H; Phillips D; Spigelman Z; Tifft C; Kishnani PS
Neuromuscul Disord; 2015 Apr; 25(4):321-32. PubMed ID: 25617983
[TBL] [Abstract][Full Text] [Related]
24. Current status of newborn screening for Pompe disease in Japan.
Sawada T; Kido J; Sugawara K; Momosaki K; Yoshida S; Kojima-Ishii K; Inoue T; Matsumoto S; Endo F; Ohga S; Hirose S; Nakamura K
Orphanet J Rare Dis; 2021 Dec; 16(1):516. PubMed ID: 34922579
[TBL] [Abstract][Full Text] [Related]
25. Late onset Pompe Disease in India - Beyond the Caucasian phenotype.
Puri RD; Setia N; N V; Jagadeesh S; Nampoothiri S; Gupta N; Muranjan M; Bhat M; Girisha KM; Kabra M; Verma J; Thomas DC; Biji I; Raja J; Makkar R; Verma IC; Kishnani PS
Neuromuscul Disord; 2021 May; 31(5):431-441. PubMed ID: 33741225
[TBL] [Abstract][Full Text] [Related]
26. Late-onset Pompe disease in France: molecular features and epidemiology from a nationwide study.
Semplicini C; Letard P; De Antonio M; Taouagh N; Perniconi B; Bouhour F; Echaniz-Laguna A; Orlikowski D; Sacconi S; Salort-Campana E; Solé G; Zagnoli F; Hamroun D; Froissart R; Caillaud C; Laforêt P;
J Inherit Metab Dis; 2018 Nov; 41(6):937-946. PubMed ID: 30155607
[TBL] [Abstract][Full Text] [Related]
27. Gene Therapy for Pompe Disease: The Time is now.
Colella P; Mingozzi F
Hum Gene Ther; 2019 Oct; 30(10):1245-1262. PubMed ID: 31298581
[TBL] [Abstract][Full Text] [Related]
28. Rare Variants in Autophagy and Non-Autophagy Genes in Late-Onset Pompe Disease: Suggestions of Their Disease-Modifying Role in Two Italian Families.
Napolitano F; Bruno G; Terracciano C; Franzese G; Palomba NP; Scotto di Carlo F; Signoriello E; De Blasiis P; Navarro S; Gialluisi A; Melone MAB; Sampaolo S; Esposito T
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807278
[TBL] [Abstract][Full Text] [Related]
29. Model-Informed Approach Supporting Approval of Nexviazyme (Avalglucosidase Alfa-ngpt) in Pediatric Patients with Late-Onset Pompe Disease.
Li RJ; Ma L; Drozda K; Wang J; Punnoose AR; Jeng LJB; Maynard JW; Zhu H; Pacanowski M
AAPS J; 2023 Jan; 25(1):16. PubMed ID: 36653728
[TBL] [Abstract][Full Text] [Related]
30. A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan.
Fukuhara Y; Fuji N; Yamazaki N; Hirakiyama A; Kamioka T; Seo JH; Mashima R; Kosuga M; Okuyama T
Mol Genet Metab Rep; 2018 Mar; 14():3-9. PubMed ID: 29124014
[TBL] [Abstract][Full Text] [Related]
31. Childhood Pompe disease: clinical spectrum and genotype in 31 patients.
van Capelle CI; van der Meijden JC; van den Hout JM; Jaeken J; Baethmann M; Voit T; Kroos MA; Derks TG; Rubio-Gozalbo ME; Willemsen MA; Lachmann RH; Mengel E; Michelakakis H; de Jongste JC; Reuser AJ; van der Ploeg AT
Orphanet J Rare Dis; 2016 May; 11(1):65. PubMed ID: 27189384
[TBL] [Abstract][Full Text] [Related]
32. Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant Cohort.
Duong T; Kishnani PS; An Haack K; Foster MC; Gibson JB; Wilson C; Hahn SH; Hillman R; Kronn D; Leslie ND; Peña LDM; Sparks SE; Stockton DW; Tanpaiboon P; Day JW;
J Neuromuscul Dis; 2022; 9(6):713-730. PubMed ID: 36214004
[TBL] [Abstract][Full Text] [Related]
33. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
[TBL] [Abstract][Full Text] [Related]
34. Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe Registry.
Kishnani PS; Kronn D; Suwazono S; Broomfield A; Llerena J; Al-Hassnan ZN; Batista JL; Wilson KM; Periquet M; Daba N; Hahn A; Chien YH
Orphanet J Rare Dis; 2023 Dec; 18(1):381. PubMed ID: 38057861
[TBL] [Abstract][Full Text] [Related]
35. Broad variation in phenotypes for common GAA genotypes in Pompe disease.
Niño MY; In't Groen SLM; de Faria DOS; Hoogeveen-Westerveld M; van den Hout HJMP; van der Ploeg AT; Bergsma AJ; Pijnappel WWMP
Hum Mutat; 2021 Nov; 42(11):1461-1472. PubMed ID: 34405923
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomic characterization of clinical skeletal muscle biopsy from late-onset Pompe patients.
Kinton S; Dufault MR; Zhang M; George K
Mol Genet Metab; 2023 Mar; 138(3):107526. PubMed ID: 36774918
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease.
Mori M; Haskell G; Kazi Z; Zhu X; DeArmey SM; Goldstein JL; Bali D; Rehder C; Cirulli ET; Kishnani PS
Mol Genet Metab; 2017 Dec; 122(4):189-197. PubMed ID: 29122469
[TBL] [Abstract][Full Text] [Related]
38. Clinical and Molecular Disease Spectrum and Outcomes in Patients with Infantile-Onset Pompe Disease.
Gupta N; Kazi ZB; Nampoothiri S; Jagdeesh S; Kabra M; Puri RD; Muranjan M; Kalaivani M; Rehder C; Bali D; Verma IC; Kishnani PS
J Pediatr; 2020 Jan; 216():44-50.e5. PubMed ID: 31606152
[TBL] [Abstract][Full Text] [Related]
39. An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease.
Kulessa M; Weyer-Menkhoff I; Viergutz L; Kornblum C; Claeys KG; Schneider I; Plöckinger U; Young P; Boentert M; Vielhaber S; Mawrin C; Bergmann M; Weis J; Ziagaki A; Stenzel W; Deschauer M; Nolte D; Hahn A; Schoser B; Schänzer A
Neuropathol Appl Neurobiol; 2020 Jun; 46(4):359-374. PubMed ID: 31545528
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
